Protein-based therapy shows promise against resistant leukemia

27 enero 2015

The efficacy and safety of the new fusion protein has been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients with ALL. Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Z384Qxp5tmU/150126201909.htm

Volver